Arcutis Biotherapeutics Clinical Site 37

Surrey, British Columbia V3V0C6

0 studies enrolling now · 2 studies all time

What they study most

Scalp Psoriasis, Seborrheic Dermatitis

Studies at this site

• Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) — Completed
• Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM) — Completed